ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Biodegradable Core-Shell Magnetic Microrobots With High Cell Capacity for Precise Co-Delivery of Stem Cells and Bioactive Molecules.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structural Evolution of Biomedical Microrobots: From Rigid to Soft to Rigid-Soft Integrated Systems.Gels (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Cell-loaded magnetic microrobots hold promise for the targeted delivery of stem cells in tissue regeneration. However, achieving high cell-loading capacity alongside effective co-delivery of functional bioactive molecules remains a major challenge. Herein, we present a biodegradable magnetic microrobot featuring a core-shell architecture, designed to co-deliver stem cells and bioactive molecules. These microrobots are fabricated using a rotation-induced inertial focusing technique, which allows control over their size and morphology while significantly enhancing cell-loading capacity. The core, composed of a biodegradable magnetic microsphere (MMS), enables external magnetic navigation and sustained drug release, while the outer shell, formed by mesenchymal stem cells (MSCs), ensures therapeutic viability. The microrobots demonstrate robust magnetic maneuverability and spatial control even in complex and viscous environments. We validated their efficacy in both a rabbit in vivo model and an ex vivo human cartilage model, where co-delivery of MSCs and transforming growth factor-β1 (TGF-β) led to significant improvements in cartilage repair and functional tissue regeneration. This biodegradable core-shell microrobot offers a scalable, multifunctional platform for efficient co-delivery of cells and bioactive molecules, with strong potential for clinical translation in regenerative medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.